Vanicoside B

CAS : 155179-21-8

Ref. 3D-FGA17921

Informations sur le produit

• Nom: Vanicoside B
• Synonymes: α-D-Glucopyranoside, 1,3,6-tris-O-[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-β-D-fructofuranosyl, 6-[3-(4-hydroxy-3-methoxyphenyl)-2-propenoate], [1[1(E),3(E),6(E)],6(E)]-, α-D-Glucopyranoside, 1,3,6-tris-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-β-D-fructofuranosyl, 6-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate], α-D-Glucopyranoside, 1,3,6-tris-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-β-D-fructofuranosyl, 6-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate]

Description

Vanicoside B is a potent inhibitor of kinases, a group of proteins that play crucial roles in cell signaling and regulation. It is found in medicinal plants and has been shown to induce apoptosis, or programmed cell death, in tumor cells. Vanicoside B is an analog of other anticancer compounds and has been found to be effective against various types of cancer in human cell lines. This compound inhibits the activity of several kinases involved in cancer progression, including those associated with angiogenesis and metastasis. Vanicoside B has also been studied for its potential as a urinary cancer biomarker, as it is present at higher levels in the urine of patients with bladder cancer compared to healthy individuals. Its potential as a therapeutic agent for Chinese herbal medicine is currently being investigated.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 956.9 g/mol
• Formule: C₄₉H₄₈O₂₀
• Degré de pureté: Min. 95%